| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Moleculin Biotech, Inc. | Director | Stock Options (right to buy) | 164,001 | 12 Nov 2025 | Direct | ||
| Checkmate Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | 31 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MBRX | Moleculin Biotech, Inc. | 12 Nov 2025 | 1 | $0 | 4 | Director | 14 Nov 2025, 16:07 |
| MBRX | Moleculin Biotech, Inc. | 04 Nov 2024 | 1 | $0 | 4 | Director | 06 Nov 2024, 20:06 |
| MBRX | Moleculin Biotech, Inc. | 25 May 2023 | 1 | $0 | 4 | Director | 26 May 2023, 17:16 |
| MBRX | Moleculin Biotech, Inc. | 20 Jun 2022 | 2 | $0 | 4 | Director | 22 Jun 2022, 19:02 |
| CMPI | Checkmate Pharmaceuticals, Inc. | 31 May 2022 | 1 | $0 | 4 | Director | 31 May 2022, 10:06 |
| MBRX | Moleculin Biotech, Inc. | 01 Mar 2022 | 1 | $0 | 4 | Director | 02 Mar 2022, 20:48 |
| MBRX | Moleculin Biotech, Inc. | 01 Mar 2022 | 0 | $0 | 3 | Director | 02 Mar 2022, 20:47 |
| CMPI | Checkmate Pharmaceuticals, Inc. | 16 Dec 2021 | 1 | $0 | 4 | Director | 17 Dec 2021, 19:22 |
| CMPI | Checkmate Pharmaceuticals, Inc. | 16 Dec 2021 | 0 | $0 | 3 | Director | 17 Dec 2021, 19:19 |